MAPK3 and psychiatric disorder: These results might provide insights into the further development of MAPK3 inhibitors as potential therapeutics for treating CO-induced mental disorders in patients, although it is generally accepted that the CO exposure levels and conditions in the mouse model were highly controlled and may not reflect real-world human exposure.